Answers are grounded in this paper and cite their sources.
Mandates from federal funding agencies to refocus research toward translational medicine and heightened expectations of patients have put substantial pressure on clinicians to serve active and critical roles in the translational process. Although the clinician scientist is well-poised to interpret and synthesize knowledge discoveries in genomic, molecular, and clinical sciences into improved patient outcomes, the landscape of modern data-driven molecular medicine has come to be profoundly unaccommodating to those best poised to explore it.
No takes yet. Share an insight, caveat, or question.
Dudley et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: